Science|Business
Policy Analysis: Investment, Policy
Horizon 2020 Special Coverage
The Innovation Connection - The 2014 Science|Business Summit
The 2014 Science|Business Summit will bring together leaders from research, industry and policy to debate current future trends needed to unleash Europe's technological potential.
Berlin - 07 October 2014
So you want to start a company?
A workshop on forming a university spin-out company. Jointly organised by Science|Business and ASTP Proton as part of the ESOF conference.
Copenhagen - 25 June 2014
ACES Selection Committee
The Academic Enterprise Awards (ACES) Selection Committee meets to short list the finalists of the 2014 awards.
Copenhagen - 23 June 2014
The value(s) of science
With Europe’s biggest-ever research programme, Horizon 2020, now underway, Science|Business gathered several leaders in European research, industry and policy to debate the ethical questions that may arise. Their reflections, gathered here, are part of a Science|Business effort...
Published:
It’s gene therapy, stupid

It is time to drop euphemisms like DNA medicines and gene-based medicines. Gene therapy, says Nuala Moran, has made it through to the commercial mainstream.

Science|Business senior editor Nuala Moran: it is what it is.

It is time to drop euphemisms like DNA medicines and gene-based medicines: gene therapy has made it through to the commercial mainstream.

More than 17 years after the first (supposedly) successful treatment was publicised, a big-ticket, big-pharma deal was signed for a gene therapy product last week, when Sanofi-Aventis agreed a €518 million licence for Oxford BioMedica plc’s TroVax,...

This page requires a Science|Business Network Membership

This page is available to Science|Business Network Members only. If you are already a member then please log in (above).

Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.

Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.

Be where innovation begins – become a member. Click here to learn more.



Related subjects: Drug development, Gene therapy

Advertisement